Lee, S. W., Oh, J., Kim, A. H., Ji, S. C., Park, S., Yoon, S. H., . . . Lee, S. (2020). Oral absorption of voriconazole is affected by SLCO2B1 c.396T>C genetic polymorphism in CYP2C19 poor metabolizers. The pharmacogenomics journal, 20(6), 792-800. https://doi.org/10.1038/s41397-020-0166-1
Chicago Style (17th ed.) CitationLee, Sang Won, et al. "Oral Absorption of Voriconazole Is Affected by SLCO2B1 C.396T>C Genetic Polymorphism in CYP2C19 Poor Metabolizers." The Pharmacogenomics Journal 20, no. 6 (2020): 792-800. https://doi.org/10.1038/s41397-020-0166-1.
MLA (9th ed.) CitationLee, Sang Won, et al. "Oral Absorption of Voriconazole Is Affected by SLCO2B1 C.396T>C Genetic Polymorphism in CYP2C19 Poor Metabolizers." The Pharmacogenomics Journal, vol. 20, no. 6, 2020, pp. 792-800, https://doi.org/10.1038/s41397-020-0166-1.